All posts by GTCbio


Where do we stand with cell therapy in diabetes?

GTCbio | February 24th, 2017

Diabetes results from the dysfunction and/or destruction of the insulin producing beta cells in the pancreatic islet. Replacement of beta cells by using progenitor or differentiated stem cells is a promising strategy to treat diabetes.

Diabetes summit in Boston will showcase patient entrepreneurs who are driving innovation with passion.

GTCbio | February 13th, 2017

Diabetes is a chronic disease that has a significant impact on the quality of life for the victims of the disease. It is no surprise that diabetes patients are tired of waiting for new therapies and technologies that will help improve the quality of life beyond current standard of care and perhaps even cure the…read more

Changing conferences to transformational platforms

Satish Medicetty | February 2nd, 2017

Few months ago when I acquired GTCbio, a company that develops and organizes conferences, my colleagues and friends were wondering if this was a change in my biotech & pharma career path. However, I see this as a strategic opportunity to create a platform that can discuss new  ideas and technologies to enable transformation of future…read more